Logo image of SLAB

SILICON LABORATORIES INC (SLAB) Stock Fundamental Analysis

NASDAQ:SLAB - Nasdaq - US8269191024 - Common Stock - Currency: USD

131.16  -2.01 (-1.51%)

After market: 131.16 0 (0%)

Fundamental Rating

4

Taking everything into account, SLAB scores 4 out of 10 in our fundamental rating. SLAB was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for SLAB as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, SLAB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SLAB has reported negative net income.
In the past year SLAB has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: SLAB reported negative net income in multiple years.
In multiple years SLAB reported negative operating cash flow during the last 5 years.
SLAB Yearly Net Income VS EBIT VS OCF VS FCFSLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

SLAB's Return On Assets of -15.62% is on the low side compared to the rest of the industry. SLAB is outperformed by 80.00% of its industry peers.
SLAB's Return On Equity of -17.69% is on the low side compared to the rest of the industry. SLAB is outperformed by 73.64% of its industry peers.
Industry RankSector Rank
ROA -15.62%
ROE -17.69%
ROIC N/A
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
SLAB Yearly ROA, ROE, ROICSLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

Looking at the Gross Margin, with a value of 53.42%, SLAB is in the better half of the industry, outperforming 70.91% of the companies in the same industry.
SLAB's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for SLAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
SLAB Yearly Profit, Operating, Gross MarginsSLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

More info and screens

9

2. Health

2.1 Basic Checks

SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SLAB has more shares outstanding
The number of shares outstanding for SLAB has been reduced compared to 5 years ago.
SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SLAB Yearly Shares OutstandingSLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SLAB Yearly Total Debt VS Total AssetsSLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

SLAB has an Altman-Z score of 19.86. This indicates that SLAB is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SLAB (19.86) is better than 89.09% of its industry peers.
There is no outstanding debt for SLAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.86
ROIC/WACCN/A
WACC9.81%
SLAB Yearly LT Debt VS Equity VS FCFSLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SLAB has a Current Ratio of 6.15. This indicates that SLAB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.15, SLAB belongs to the best of the industry, outperforming 86.36% of the companies in the same industry.
A Quick Ratio of 5.07 indicates that SLAB has no problem at all paying its short term obligations.
SLAB has a better Quick ratio (5.07) than 83.64% of its industry peers.
Industry RankSector Rank
Current Ratio 6.15
Quick Ratio 5.07
SLAB Yearly Current Assets VS Current LiabilitesSLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

SLAB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -95.56%.
SLAB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -25.29%.
Measured over the past years, SLAB shows a small growth in Revenue. The Revenue has been growing by 4.28% on average per year.
EPS 1Y (TTM)-95.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.3%
Revenue 1Y (TTM)-25.29%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%67.06%

3.2 Future

The Earnings Per Share is expected to grow by 65.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.97% on average over the next years. This is a very strong growth
EPS Next Y138.34%
EPS Next 2Y89.25%
EPS Next 3Y65.56%
EPS Next 5YN/A
Revenue Next Year34.61%
Revenue Next 2Y27.05%
Revenue Next 3Y22.97%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SLAB Yearly Revenue VS EstimatesSLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
SLAB Yearly EPS VS EstimatesSLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SLAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 48.22, the valuation of SLAB can be described as expensive.
Based on the Price/Forward Earnings ratio, SLAB is valued a bit more expensive than the industry average as 62.73% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of SLAB to the average of the S&P500 Index (21.27), we can say SLAB is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 48.22
SLAB Price Earnings VS Forward Price EarningsSLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLAB Per share dataSLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

SLAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SLAB's earnings are expected to grow with 65.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.25%
EPS Next 3Y65.56%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLAB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SILICON LABORATORIES INC

NASDAQ:SLAB (5/16/2025, 8:22:28 PM)

After market: 131.16 0 (0%)

131.16

-2.01 (-1.51%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)07-22 2025-07-22/bmo
Inst Owners104.06%
Inst Owner Change-0.29%
Ins Owners1.77%
Ins Owner Change0.15%
Market Cap4.26B
Analysts72.22
Price Target133.75 (1.97%)
Short Float %5.55%
Short Ratio4.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)18.8%
Min EPS beat(2)-0.51%
Max EPS beat(2)38.1%
EPS beat(4)3
Avg EPS beat(4)14.93%
Min EPS beat(4)-0.51%
Max EPS beat(4)38.1%
EPS beat(8)4
Avg EPS beat(8)9.5%
EPS beat(12)8
Avg EPS beat(12)16.72%
EPS beat(16)12
Avg EPS beat(16)23.49%
Revenue beat(2)0
Avg Revenue beat(2)-1.56%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)-1.26%
Revenue beat(4)1
Avg Revenue beat(4)-0.55%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)1.68%
Revenue beat(8)1
Avg Revenue beat(8)-0.74%
Revenue beat(12)4
Avg Revenue beat(12)-0.2%
Revenue beat(16)6
Avg Revenue beat(16)-4.49%
PT rev (1m)-8.3%
PT rev (3m)2.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.22%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)-0.1%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 48.22
P/S 7.29
P/FCF N/A
P/OCF N/A
P/B 3.94
P/tB 6.38
EV/EBITDA N/A
EPS(TTM)-0.88
EYN/A
EPS(NY)2.72
Fwd EY2.07%
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS18
BVpS33.26
TBVpS20.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.62%
ROE -17.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.42%
FCFM N/A
ROA(3y)-4.6%
ROA(5y)11.68%
ROE(3y)-4.68%
ROE(5y)16.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.26%
GM growth 5Y-2.01%
F-Score3
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.18%
Cap/Sales 2.01%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.15
Quick Ratio 5.07
Altman-Z 19.86
F-Score3
WACC9.81%
ROIC/WACCN/A
Cap/Depr(3y)38.21%
Cap/Depr(5y)38.21%
Cap/Sales(3y)2.48%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.3%
EPS Next Y138.34%
EPS Next 2Y89.25%
EPS Next 3Y65.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.29%
Revenue growth 3Y-6.76%
Revenue growth 5Y4.28%
Sales Q2Q%67.06%
Revenue Next Year34.61%
Revenue Next 2Y27.05%
Revenue Next 3Y22.97%
Revenue Next 5YN/A
EBIT growth 1Y-586.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year157.93%
EBIT Next 3Y64.08%
EBIT Next 5YN/A
FCF growth 1Y51.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y54.17%
OCF growth 3YN/A
OCF growth 5YN/A